Cleared Traditional

K840236 - EMIT ST SERUM BENZODIAZEPINE ASSAY (FDA 510(k) Clearance)

Mar 1984
Decision
59d
Days
Class 2
Risk

K840236 is an FDA 510(k) clearance for the EMIT ST SERUM BENZODIAZEPINE ASSAY. This device is classified as a Enzyme Immunoassay, Benzodiazepine (Class II - Special Controls, product code JXM).

Submitted by Syva Co. (Walker, US). The FDA issued a Cleared decision on March 19, 1984, 59 days after receiving the submission on January 20, 1984.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3170.

Submission Details

510(k) Number K840236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 1984
Decision Date March 19, 1984
Days to Decision 59 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code JXM — Enzyme Immunoassay, Benzodiazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3170

Similar Devices — JXM Enzyme Immunoassay, Benzodiazepine

All 7
Alinity c Benzodiazepines Reagent Kit
K243498 · Microgenics Corporation · Dec 2024
ONLINE DAT Benzodiazepines II
K221765 · Roche Diagnostics · Dec 2022
CEDIA Benzodiazepine Assay
K190968 · Microgenics Corporation · Dec 2019
DRI Benzodiazepine Assay
K173963 · Microgenics Corporation · Feb 2018
Healgen Multi-Drug Urine Test Cup
K163704 · Healgen Scientific, LLC · Aug 2017
Healgen Multi-Drug Urine Test Cup, Healgen Multi-Drug Urine Test Dip Card
K153597 · Healgen Scientific, LLC · May 2016